scholarly journals A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)

2016 ◽  
Vol 7 (5) ◽  
pp. 703-710 ◽  
Author(s):  
Seiya Shimoda ◽  
Miki Sato ◽  
Taiji Sekigami ◽  
Hiroyuki Motoshima ◽  
Ryohei Yoshimura ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Observational Study ◽  
Insulin Glargine ◽  
Insulin Therapy ◽  
Prospective Observational Study ◽  
Insulin Degludec ◽  
Bolus Insulin ◽  
Basal Bolus

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

2013 ◽  
Vol 60 (5) ◽  
pp. 249-253
Author(s):  
Irene Vinagre ◽  
Juan Sánchez-Hernández ◽  
José Luis Sánchez-Quesada ◽  
Miguel Ángel María ◽  
Alberto de Leiva ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Bolus Insulin ◽  
Basal Bolus ◽  
Term Type ◽  
Diabetes Patients

GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

2018 ◽  
Vol 35 (1) ◽  
pp. e3082 ◽  
Author(s):  
Marco Castellana ◽  
Angelo Cignarelli ◽  
Francesco Brescia ◽  
Luigi Laviola ◽  
Francesco Giorgino
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Receptor Agonist ◽  
Meta Analysis ◽  
Bolus Insulin ◽  
Basal Bolus

scholarly journals U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes

2012 ◽  
Vol 14 (6) ◽  
pp. 505-507 ◽  
Author(s):  
Jolene Brown Lowery ◽  
Amy C. Donihi ◽  
Mary T. Korytkowski
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Bolus Insulin ◽  
Basal Bolus
Sign in / Sign up

Export Citation Format

Share Document